| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/bioinformatics/OrtusoLA06 |
| P356 | DOI | 10.1093/BIOINFORMATICS/BTL115 |
| P698 | PubMed publication ID | 16567363 |
| P5875 | ResearchGate publication ID | 7212646 |
| P50 | author | Francesco Ortuso | Q42680440 |
| Thierry Langer | Q52107262 | ||
| Stefano Alcaro | Q56811069 | ||
| P2093 | author name string | Thierry Langer | |
| Stefano Alcaro | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1449-1455 | |
| P577 | publication date | 2006-03-27 | |
| P1433 | published in | Bioinformatics | Q4914910 |
| P1476 | title | GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition | |
| P478 | volume | 22 |
| Q89338559 | A Survey of Data Mining and Deep Learning in Bioinformatics |
| Q90619451 | All in One: Cavity Detection, Druggability Estimate, Cavity-Based Pharmacophore Perception, and Virtual Screening |
| Q30386769 | Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations |
| Q55120002 | Computer-Aided Drug Design in Epigenetics. |
| Q43246211 | Detecting and understanding genetic and structural features in HIV-1 B subtype V3 underlying HIV-1 co-receptor usage |
| Q43117452 | DrugOn: a fully integrated pharmacophore modeling and structure optimization toolkit |
| Q56980133 | From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modeling |
| Q28481038 | HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors |
| Q40119011 | How to implement grid technology in tissue-based diagnosis: diagnostic surgical pathology |
| Q40680044 | Identification of Novel Potential gp120 of HIV-1 Antagonist Using Per-Residue Energy Contribution-Based Pharmacophore modelling |
| Q34185134 | In silico screening of quadruplex-binding ligands |
| Q37711622 | Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations |
| Q58137084 | Molecular interaction fields in drug discovery: recent advances and future perspectives |
| Q47937897 | PLI: a web-based tool for the comparison of protein-ligand interactions observed on PDB structures |
| Q38216045 | Pharmacophore modeling technique applied for the discovery of proteasome inhibitors |
| Q36087114 | Pharmacophores in Drug Research. |
| Q90430431 | Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations |
| Q34329252 | Protein-protein binding site identification by enumerating the configurations |
| Q38078403 | Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery |
| Q38252759 | Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors. |
| Q55397689 | Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches. |
| Q42917410 | Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors |
| Q39417388 | State-of-the-art and dissemination of computational tools for drug-design purposes: a survey among Italian academics and industrial institutions |
| Q35769340 | Structural neighboring property for identifying protein-protein binding sites |
| Q21090822 | Structure prediction and validation of the ERK8 kinase domain |
| Q42283539 | Synthesis and biological evaluation of novel antiviral agents as protein-protein interaction inhibitors |
| Q56962039 | Truly Target-Focused Pharmacophore Modeling: A Novel Tool for Mapping Intermolecular Surfaces |
Search more.